ArticleJournal of computer-aided molecular design2026
DFT and molecular docking-guided investigation of mixed-ligand octahedral Fe(III) and Cu(II) Schiff-base and albendazole complexes with antimicrobial potential.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This work describes the synthesis of two novel octahedral mixed ligand transition metal complexes, FeHLAB and CuHLAB, which incorporate a combination of a Schiff-base (HL) ligand and albendazole (AB). Both of these complexes were synthesized in high yields of 88% and 85% for FeHLAB and CuHLAB, respectively, and both are thermally stable solids with a melting point of > 300 °C. Various characterization tools such as CHN & metal analysis, FT-IR, UV-Vis, magnetic susceptibility, mass spectra, molar conductance, and DFT analysis reveal an octahedral geometry involving N & O-donors along with chloride ions. The DFT results reveal that CuHLAB and FeHLAB have small HOMO-LUMO energy gaps (CuHLAB: 1.28 eV; FeHLAB: 2.96 eV) with enhanced softness and electrophilicity. All these make these complexes more chemically reactive. Antimicrobial activity was conducted, showing that metal complexes had high activity against four bacteria (E. coli, P. aeruginosa, B. cereus, S. aureus) and two fungi (A. flavus, C. albicans). CuHLAB was more active compared to FeHLAB and approached the activity of commercial medicines, which was in the range of 40-50 µM for the CuHLAB complex. A molecular docking study with E. coli DNA gyrase B (PDB code: 4DUH) showed that there was a binding affinity of - 8.80 kcal/mol for CuHLAB, which was mediated by hydrogen bonding, electrostatic, and hydrophobic interactions. This was consistent with its observed in vitro antimicrobial properties. In general, these mixed transition metal complexes, particularly CuHLAB, show strong antimicrobial activity, which provides an important approach to conserving water, soil, and public health as well as potentially thwarting economic loss.
Indexed as
Identifiers
41870768What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.